Patent details

EP3914247 Title: USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3914247
WO Application Number:
US2020014531
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20708283.5
WO Publication Number:
WO2020154354
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
22/01/2020
Grant date:
13/11/2024
EP Publication Date:
01/12/2021
WO Publication Date:
30/07/2020
Claims Translations Received Date:
Claims Translation B1 Received Date:
09/01/2025
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/11/2024
EP B1 Publication Date:
13/11/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
21/01/2040
Lapsed By Expiration Date:
Patent Validated Date:
23/01/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
13/11/2024
 
 

 

Name:
Amicus Therapeutics, Inc.
Address:
3675 Market Street, Philadelphia, PA 19104, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
22/01/2025
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
SKUBAN, Nina
Address:
Cranbury, New Jersey 08512, United States of America (US)

2

Name:
LAGAST, Hjalmar
Address:
Cranbury, New Jersey 08512, United States of America (US)

Priority

Priority Patent Number:
201962795524 P
Priority Date:
22/01/2019
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/445; A61P 9/00; A61P 25/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
04/25
Publication date:
24/01/2025
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
46/24
Publication date:
13/11/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202451
Publication date:
18/12/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202446
Publication date:
13/11/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/01/2026
Annual Fee Number:
7
Annual Fee Amount:
220 Euro
Last Annual Payment Date:
14/12/2024
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
160 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
22/01/2025 Outgoing Correspondence Letter no formal defects 1 PDF /7/3/2/9/5/0801059237/docs/ep20708283.5_1_640468l271.pdf
09/01/2025 Claims First filed claims 2 PDF /7/3/2/9/5/0801059237/docs/ep20708283.5_0_claims20250109174502231.pdf